Molecular Detection of Mycobacterium tuberculosis (MTB) and Rifampicin Resistant Strain among Subjects Accessing Health Care at Federal Medical Centre,Yenegoa, Bayelsa State; Nigeria

O. Azuonwu
{"title":"Molecular Detection of Mycobacterium tuberculosis (MTB) and Rifampicin Resistant Strain among Subjects Accessing Health Care at Federal Medical Centre,Yenegoa, Bayelsa State; Nigeria","authors":"O. Azuonwu","doi":"10.21767/2172-0479.100120","DOIUrl":null,"url":null,"abstract":"Background: An increasing global incidence of Mycobacterium Tuberculosis (MTB), and emergence of drug resistant strains of MTB, have critically promoted the urgent need to explore better effective methods that can rapidly detect MTB, and identify drug-resistant cases as recommended by World Health Organization report of 2008. Globally, multi-drug-resistant strains of MTB are increasingly becoming a huge public health issue, which has adversely affected the health care delivery of patients, especially in developing communities with limited functioning health care facility. Nonetheless, the aim and focus of the study is to evaluate the trend of rifampicin resistance strains of MTB among patients accessing care at the University of Port Harcourt Teaching Hospital. Methods: This observational cross-sectional study which utilized stratified proportionate random technique, was designed to evaluate the molecular detection, as well as the prevalence of MTB and multidrug resistant TB specifically RIF among the studied population. Results: The study population were 204 subjects recruited randomly, with a mean age of 37.23 ± 16.68 years and were categorized based on sex, 93 (45.6%) males and 111 (54.4%) females respectively. The MTB detected were 21 (10.3%) while 183 (89.7%) were negative. Also, drug resistant test was performed specifically for RIF to ascertain RIF resistant strain and the non-RIF resistant strains; only 6 (2.9%) were resistant to RIF while 197 (96.6%) were not resistant to RIF. Correlation analysis of MTB detected between sex, age and resistant to RIF showed nonsignificant association (p>0.05). The prevalence rates include: 2.9% and 7.4% for RIF Resistance and Non-RIF resistance respectively. Chi square result reported about 90% non-significance and 10% significance which occurred in the counts between RIF resistant and MTB detected (p<0.05). Conclusion: The use of dependable molecular detection of MTB method has been able to provide strong epidemiological impetus for an enhanced MTB diagnosis and management to be encouraged and should be sustained, especially in resources limited regions like Nigeria, with massive challenges of prompt and accurate diagnosis of the infection. However, it is strongly believed that continuous leveraging on the potency of the molecular diagnostic approach will help to uncover the rifampicin resistance strains, which obviously would have been a huge challenge with the routine microscopic smear method.","PeriodicalId":89642,"journal":{"name":"Translational biomedicine","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21767/2172-0479.100120","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational biomedicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21767/2172-0479.100120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Background: An increasing global incidence of Mycobacterium Tuberculosis (MTB), and emergence of drug resistant strains of MTB, have critically promoted the urgent need to explore better effective methods that can rapidly detect MTB, and identify drug-resistant cases as recommended by World Health Organization report of 2008. Globally, multi-drug-resistant strains of MTB are increasingly becoming a huge public health issue, which has adversely affected the health care delivery of patients, especially in developing communities with limited functioning health care facility. Nonetheless, the aim and focus of the study is to evaluate the trend of rifampicin resistance strains of MTB among patients accessing care at the University of Port Harcourt Teaching Hospital. Methods: This observational cross-sectional study which utilized stratified proportionate random technique, was designed to evaluate the molecular detection, as well as the prevalence of MTB and multidrug resistant TB specifically RIF among the studied population. Results: The study population were 204 subjects recruited randomly, with a mean age of 37.23 ± 16.68 years and were categorized based on sex, 93 (45.6%) males and 111 (54.4%) females respectively. The MTB detected were 21 (10.3%) while 183 (89.7%) were negative. Also, drug resistant test was performed specifically for RIF to ascertain RIF resistant strain and the non-RIF resistant strains; only 6 (2.9%) were resistant to RIF while 197 (96.6%) were not resistant to RIF. Correlation analysis of MTB detected between sex, age and resistant to RIF showed nonsignificant association (p>0.05). The prevalence rates include: 2.9% and 7.4% for RIF Resistance and Non-RIF resistance respectively. Chi square result reported about 90% non-significance and 10% significance which occurred in the counts between RIF resistant and MTB detected (p<0.05). Conclusion: The use of dependable molecular detection of MTB method has been able to provide strong epidemiological impetus for an enhanced MTB diagnosis and management to be encouraged and should be sustained, especially in resources limited regions like Nigeria, with massive challenges of prompt and accurate diagnosis of the infection. However, it is strongly believed that continuous leveraging on the potency of the molecular diagnostic approach will help to uncover the rifampicin resistance strains, which obviously would have been a huge challenge with the routine microscopic smear method.
巴耶尔萨州叶内戈联邦医疗中心就医对象中结核分枝杆菌和利福平耐药菌株的分子检测尼日利亚
背景:随着全球结核分枝杆菌(MTB)发病率的增加以及耐药菌株的出现,迫切需要探索更有效的方法来快速发现MTB,并根据世界卫生组织2008年报告的建议确定耐药病例。在全球范围内,耐多药结核菌株正日益成为一个巨大的公共卫生问题,这对患者的卫生保健服务产生了不利影响,特别是在卫生保健设施功能有限的发展中社区。尽管如此,本研究的目的和重点是评估在哈科特港大学教学医院就诊的患者中耐利福平结核分枝杆菌菌株的趋势。方法:本观察性横断面研究采用分层比例随机技术,旨在评估研究人群中MTB和耐多药结核病特异性RIF的分子检测以及患病率。结果:随机招募204例受试者,平均年龄37.23±16.68岁,按性别分类,男性93例(45.6%),女性111例(54.4%)。MTB检出21例(10.3%),阴性183例(89.7%)。并对RIF进行了特异性耐药试验,确定了RIF耐药菌株和非RIF耐药菌株;耐药6株(2.9%),不耐药197株(96.6%)。MTB检出率与性别、年龄与RIF耐药的相关性分析显示无显著相关性(p < 0.05)。RIF耐药率为2.9%,非RIF耐药率为7.4%。卡方结果显示,RIF耐药数与MTB检出数无显著性差异约90%,显著性差异约10% (p<0.05)。结论:可靠的MTB分子检测方法的使用为加强MTB的诊断和管理提供了强有力的流行病学动力,值得鼓励并应持续下去,特别是在尼日利亚等资源有限的地区,及时准确诊断感染面临巨大挑战。然而,我们坚信,持续利用分子诊断方法的效力将有助于发现利福平耐药菌株,这显然是常规显微镜涂片法的巨大挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信